Sasakawa, Yuji
Okamoto, Naoki
Fujii, Maya
Kato, Jyoichiro
Yuzawa, Yukio
Inaguma, Daijo
Funding for this research was provided by:
Aichi Kidney Foundation
Japanese Association of Dialysis Physicians
Article History
Received: 14 October 2021
Accepted: 21 March 2022
First Online: 2 April 2022
Declarations
:
: This study was performed according to the Ethics of Clinical Research (the Helsinki Declaration). This study was approved by Fujita Health University Center for Clinical Trial and Research Support (approval number: HM16–373). All participants involved in this study were gave informed consent after explanation of the purpose of the study and agreed to participate. This study was registered in the clinical trial registry (UMIN 000026756) on April 1, 2017.
: Not applicable.
: D. Inaguma received lecture fees from Ono Pharmaceutical Co., Ltd. and Kyowa Kirin Co., Ltd. Y. Yuzawa received research support grants from Otsuka Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and Chugai Pharmaceutical Co., Ltd. The other authors declare that they have no competing interests.